The gp120-CD4 interface: structural, immunological and pathological considerations.
Kieber-Emmons
T
T
IDEC Pharmaceuticals Corporation, La Jolla, CA 92037.
Jameson
B A
BA
Morrow
W J
WJ
D000595:Amino Acid Sequence; D001665:Binding Sites; D015704:CD4 Antigens / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D006031:Glycosylation; D015699:HIV Envelope Protein gp120 / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D015658:HIV Infections / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008969:Molecular Sequence Data; D014765:Viral Vaccines / Q000276:immunology
D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D007136:Immunoglobulins; D014765:Viral Vaccines